🕵️ Q/C Technologies, Inc. ($QCLS)
SEC insider & ownership activity, last 12 months · CIK 1321834 · every row links its SEC filing
Over the last 12 months insiders bought $6K with no open-market selling against it. Voss Chelsea Sierra bought $6K in discretionary trades (Mar). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $6K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Voss Chelsea Sierra | 1 | $6K | 0 | – | Mar 30, 2026 |
| Pharmacyte Biotech, Inc. | 2 | – | 0 | – | Nov 14, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pharmacyte Biotech, Inc. | 74.0% | 13D | Nov 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jun 26, 2026 | filing ↗ |
| Other events (8.01) | Jun 26, 2026 | filing ↗ |
| Auditor change (4.01) | Mar 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 9, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 16, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 16, 2026 | filing ↗ |
| Other events (8.01) | Jan 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 16, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 8, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 8, 2025 | filing ↗ |
| Other events (8.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 14, 2025 | filing ↗ |
| Shareholder vote (5.07) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 30, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 30, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 30, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Sep 30, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 30, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 30, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 22, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 22, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 4, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Sep 4, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Sep 4, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 4, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 2, 2025 | filing ↗ |